3rd International Life Sciences Conference | LiSci 2026
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 3rd International Life Sciences Conference | LiSci 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
3rd International Life Sciences Conference (LiSci 2026)
Date: July 28–29, 2026
Event Type: Virtual Conference
Website: https://lisci2026.org/index
1️⃣ Who attends (BUYERS / ATTENDEES)
This virtual conference attracts a global audience of:
- Research scientists and academic faculty
- Biotechnology and pharmaceutical industry leaders
- Healthcare professionals and clinical researchers
- Government and regulatory affairs professionals
- Startup founders and innovation hub directors
- Procurement managers for lab equipment and software
- Investors in life science technologies
- Education and training program decision-makers
Primary Buyer Profiles: C-suite executives, R&D directors, procurement officers, partnership development managers, and innovation scouts from biotech, pharma, and research institutions.
2️⃣ Where the show is happening + attendee geographic origin
Event Location: Virtual (online platform)
Attendee Geographic Origin: Global reach with emphasis on:
- North America (40-45% estimated)
- Europe (30-35% estimated)
- Asia-Pacific (20% estimated)
- Emerging markets in Africa and Latin America
3️⃣ Audience reach
Reach Type: Global
As a virtual event with no geographic constraints, LiSci 2026 attracts participants from over 50 countries. Key focus regions include:
- Major biotech hubs (Boston, San Francisco, Berlin, Singapore)
- Academic research centers
- Government health agencies
- Emerging markets with growing life sciences sectors
4️⃣ Sample buyer company names + websites
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | thermofisher.com | Director of Research Partnerships | Major supplier of lab equipment and reagents; actively engages in academic collaborations. |
| 2 | Moderna Therapeutics | modernatx.com | Chief Scientific Officer | Leader in mRNA technology; seeks partnerships in genomics and AI-driven drug discovery. |
| 3 | Roche Diagnostics | roche-diagnostics.com | Global Head of Innovation | Key player in diagnostic technologies; interested in AI and digital health collaborations. |
| 4 | CRISPR Therapeutics | crisprtherapeutics.com | VP of Research Collaborations | Leader in gene-editing technologies; seeks academic and industry partnerships. |
| 5 | BioRad Laboratories | bio-rad.com | Senior Marketing Manager, Academia | Provides specialized research tools; targets university labs and research institutions. |
5️⃣ Job profiles, industries & event type
Key Job Profiles to Target:
- Chief Scientific Officer (CSO)
- Head of R&D
- Procurement Manager – Lab Equipment
- Business Development Director
- University Research Dean
- Regulatory Affairs Manager
- Director of Biotech Partnerships
- AI Research Scientist
- Genomics Program Lead
Industries (per Apollo classification):
- Biotechnology
- Pharmaceuticals
- Healthcare & Hospital
- Higher Education
- Medical Devices
- Information Technology (AI/Computational Biology)
- Government Administration
Event Type: Academic-industry hybrid conference focused on research presentations, technology exhibitions, and collaboration networking.
6️⃣ Estimated attendance
Expected Virtual Attendance: 2,500+ unique participants
- 1,200+ academic researchers
- 800+ industry professionals
- 300+ healthcare practitioners
- 200+ investors and policymakers
Note: Virtual format may increase accessibility but requires targeted outreach for B2B engagement.
7️⃣ Key focus areas & buyer engagement
Core Research Themes:
- Genomics & CRISPR Technologies
- AI-Driven Drug Discovery
- Synthetic Biology
- Neurotechnology
- Microbiome Engineering
- Regenerative Medicine
- Environmental Resilience
Buyer Engagement Opportunities:
- Virtual exhibitor booths for product demonstrations
- Sponsored research sessions and webinars
- Targeted networking lounges for procurement discussions
- Talent acquisition opportunities with academic institutions
8️⃣ Client-product fit note
Please share your client’s website to enable precise buyer profiling. The ideal target companies will vary significantly based on your product:
- Lab equipment suppliers: Target research institutions and biotech firms
- AI/ML platforms: Focus on computational biology teams and pharmaceutical companies
- Contract research organizations (CROs): Engage with pharmaceutical procurement managers
- Academic software: Prioritize university decision-makers and grant administrators
9️⃣ Final recommendation
LiSci 2026 offers strong value for companies seeking:
- Global exposure to research institutions
- Early-stage collaboration opportunities
- Access to emerging markets in life sciences
- Talent acquisition pipelines with top universities
Quality Rating for B2B Engagement: 8.5/10
Virtual format allows cost-effective participation but requires proactive outreach. Best suited for companies with innovative solutions in genomics, AI-driven research tools, or biotech partnerships.
Data sheet
3rd International Conference on Life Sciences (LiSci 2026) – Event Attendee & Buyer Profile Analysis
Event date: July 28–29, 2026
Location: Virtual Conference
Event status: Upcoming
Research date: June 30, 2026
Event Overview
| Event Name | 3rd International Conference on Life Sciences (LiSci 2026) |
| Event Date | July 28–29, 2026 |
| Event Status | Upcoming |
| Venue | Virtual Conference |
| City | Virtual / Not location-based |
| State / Region | Not applicable |
| Country | Not specified in reviewed official source; global virtual access |
| Organizer | Organizer name not publicly identified in the reviewed official homepage text |
| Official Event Website | lisci2026.org |
| Event Type | Virtual Conference |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; IT & Technology; Agriculture & Forestry |
| Audience Reach | Global |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for numerical attendance; high for event dates, format, and thematic scope based on official homepage content |
| Main Purpose of Event | Research presentation, scientific exchange, interdisciplinary collaboration, innovation visibility, and networking across biological, biomedical, biotech, computational, environmental, and healthcare life sciences fields |
About the Event
LiSci 2026 is the 3rd International Conference on Life Sciences, scheduled as a virtual conference on July 28–29, 2026. Based on the official event description, the conference is positioned as a multidisciplinary platform for researchers, innovators, educators, and industry leaders to discuss advances across biological and biomedical sciences, including genomics, synthetic biology, neurotechnology, AI-driven discovery, environmental resilience, immunology, diagnostics, regenerative medicine, microbiome science, and computational biology.
From a commercial and partnership perspective, the event matters because it brings together institutions and professionals involved in research funding, scientific collaboration, translational medicine, lab technologies, drug discovery, computational tools, and innovation partnerships. While the conference appears primarily research-led rather than trade-show-led, it is still relevant for lead generation into life sciences R&D, academic research centers, biotech innovation teams, healthcare research functions, and scientific software or instrumentation stakeholders. It is best suited for thought-leadership outreach, partnership building, and niche buyer identification rather than mass attendee-list selling based on publicly available attendee disclosure.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Academic researchers and faculty | Universities, research institutes, life sciences departments, translational research centers | Influence scientific tool adoption, collaboration partnerships, grant-funded purchases, and pilot evaluations | High relevance for lab equipment, bioinformatics software, sequencing, analytics, publishing, and research services |
| Biotechnology R&D leaders | Biotech startups, scale-ups, synthetic biology firms, genomics companies | Direct influence over platform selection, R&D tools, CRO/CDMO relationships, AI discovery platforms, and partnership decisions | Very high relevance for discovery platforms, assay tools, data platforms, manufacturing support, and specialized services |
| Pharmaceutical and translational medicine professionals | Pharma companies, drug discovery teams, therapeutic research units | Evaluate innovation pipelines, biomarkers, preclinical research technologies, and external scientific collaborations | High relevance for drug discovery, AI pharmacology, data services, diagnostics, and translational research support |
| Healthcare and clinical research professionals | Hospitals, medical schools, clinical research organizations, health systems | Influence clinical study design, diagnostic adoption, research infrastructure, and translational collaboration | Relevant for diagnostics, imaging, clinical research tools, data systems, and biomedical innovation partnerships |
| Computational biology and bioinformatics teams | Research labs, biotech firms, AI biology companies, data science groups | Select analysis platforms, cloud workflows, informatics vendors, and data integration solutions | Very high relevance for software, AI tools, cloud infrastructure, databases, and advanced analytics |
| Government and public research stakeholders | Public health agencies, research councils, regulatory or policy-linked scientific bodies | Influence grants, collaborative programs, policy direction, public research procurement, and scientific priorities | Relevant for public-sector research support, surveillance tools, data systems, and scientific infrastructure offerings |
| Innovation and partnership leaders | Biotech companies, universities, incubators, translational partnerships offices | Scout collaborations, licensing opportunities, strategic alliances, and joint development | Strong relevance for BD outreach, co-development, research partnerships, and innovation ecosystems |
| Lab procurement and operations stakeholders | Universities, biotech firms, pharma R&D sites, research hospitals | Assess instruments, consumables, software licenses, lab services, and operating platforms | Important for conversion of technical interest into actual purchasing activity |
| Investors and startup ecosystem participants | Venture investors, innovation hubs, accelerators, startup founders | Influence commercialization strategy, partnerships, and early market access | Relevant for visibility, partnerships, and market intelligence more than direct procurement volume |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Virtual host environment | Global online participation | Dispersed across research, biotech, healthcare, and academic institutions | Confirmed as a virtual conference in official source; no physical city venue listed |
| North America | Likely strong participation from U.S. and Canada life sciences ecosystems | High | Likely attendee profile based on conference themes in genomics, biotech, AI biology, and biomedical sciences |
| Europe | Likely participation from academic and biotech research communities | High | Virtual format supports strong accessibility for EU and UK institutions |
| Asia-Pacific | Likely attendance from research universities, biotech firms, and medical institutes | Medium to High | Scientific focus areas are relevant to major biotech hubs in East Asia, India, Singapore, and Australia |
| Latin America | Likely selective participation from universities, public health research, and biotech startups | Medium | Virtual access lowers travel barriers for emerging market researchers |
| Africa and Middle East | Likely participation from health sciences, environmental sciences, and academic research communities | Medium | Virtual scientific conferences often broaden accessibility for cross-border academic participation |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The official event description explicitly positions LiSci 2026 as a gathering for a global community of researchers, innovators, educators, and industry leaders. The virtual format further supports international participation. |
| National / Regional | Secondary applicability | Individual participating institutions may still cluster by country or research region, but the event itself is not geographically bound. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| No official current-year buyer, sponsor, exhibitor, speaker-organization, or attendee company list publicly disclosed in the reviewed official source set | Not publicly verifiable from available source text | The official homepage confirms event scope, date, and virtual format, but does not provide a validated list of participating buyer-side organizations for current-year company targeting. | lisci2026.org | R&D Director; Principal Investigator; Procurement Manager; Head of Bioinformatics; Clinical Research Director; Partnerships Director | Confirmed current-year event existence only; attendee organizations not publicly confirmed |
This event is suitable for niche B2B attendee-profile building and role-based Apollo targeting, but not for a verified current-year attendee-company list sale based on the reviewed public source set. Additional official pages such as program committee, accepted papers, agenda, or partner listings would be needed to validate individual organizations.
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Director of Research & Development | R&D | Director | Owns scientific direction, evaluates technologies, and influences budgets for research tools and collaborations |
| 2 | Principal Investigator / Lead Scientist | Research | Manager / Director / Individual Contributor | Drives tool adoption, method selection, and pilot collaboration decisions in research-heavy environments |
| 3 | Head of Bioinformatics / Computational Biology | Data Science / R&D | Head / Director | Critical buyer for analytics platforms, AI models, sequencing workflows, and data infrastructure |
| 4 | Clinical Research Director | Clinical Research | Director | Relevant where diagnostics, translational medicine, biomedical imaging, or trial-related services are offered |
| 5 | Procurement Manager | Procurement | Manager | Converts technical requirements into approved supplier purchases for instruments, software, and services |
| 6 | Strategic Sourcing Manager | Sourcing / Supply Chain | Manager | Important for vendor onboarding, contract negotiations, and category-level sourcing |
| 7 | Chief Scientific Officer | Executive / Scientific Leadership | C-Level | High-level decision-maker for strategic partnerships, innovation platforms, and scientific direction |
| 8 | Partnerships Director / Business Development Director | Business Development | Director | Key for licensing, co-development, research alliances, and commercialization opportunities |
| 9 | Lab Operations Manager | Operations | Manager | Relevant for deployment, implementation, and utilization of scientific tools and services |
| 10 | Innovation Program Director | Innovation / Strategy | Director | Screens emerging technologies and external partners for strategic fit |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Biotechnology | Core fit for genomics, synthetic biology, microbiome, and translational innovation themes | R&D tools, platform partnerships, assay services, analytics, AI biology |
| 2 | Pharmaceuticals | Relevant to drug discovery, precision medicine, pharmacology, therapeutics, and immune engineering | Drug discovery support, biomarkers, AI pharmacology, translational partnerships |
| 3 | Hospital & Health Care | Relevant to biomedical sciences, diagnostics, neurobiology, and translational medicine participation | Clinical research tools, diagnostics, imaging, data systems |
| 4 | Research | Strong fit for non-commercial scientific institutes and multidisciplinary research centers | Academic collaboration, lab tools, data infrastructure, grant-supported procurement |
| 5 | Higher Education | Conference content is strongly aligned with universities and academic science departments | Faculty outreach, lab procurement, research collaborations, software licensing |
| 6 | Medical Devices | Fit for diagnostics, imaging, neurotechnology, and biomedical instrumentation ecosystems | Instrument partnerships, translational validation, clinical research engagement |
| 7 | Information Technology & Services | Relevant to AI-driven discovery, computational biology, cloud analysis, and scientific data platforms | Bioinformatics software, data pipelines, analytics, cloud enablement |
| 8 | Computer Software | Appropriate for vendors serving life-science modeling, visualization, AI, and workflow orchestration | Scientific software sales, platform demos, enterprise deployments |
| 9 | Environmental Services | Relevant because the conference includes environmental and ecological sciences | Environmental biology tools, ecological data systems, resilience research partnerships |
| 10 | Agriculture | Official scope includes agriculture-related life science dialogue | Ag-biotech research tools, genomics, microbiome, sustainability applications |
| 11 | Government Administration | Relevant for public health, public research funding, and scientific program participation | Public-sector research programs, surveillance, grants, and infrastructure outreach |
| 12 | Health, Wellness & Fitness | Secondary fit for applied health-science and preventive innovation stakeholders | Research collaborations, diagnostics, wellness science platforms |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Not confirmed | Reviewed official homepage text | No attendee number displayed in the provided official source content |
| Exhibitor count | Not publicly confirmed | Not confirmed | Reviewed official homepage text | Conference appears content-led; no exhibitor directory found in the reviewed source excerpt |
| Buyer count | Not publicly confirmed | Not confirmed | Reviewed official homepage text | No buyer program or hosted-buyer data identified |
| Speaker count | Not publicly confirmed | Not confirmed | Reviewed official homepage text | Program committee page exists in navigation, but details were not available in the provided source text |
| Sponsor count | Not publicly confirmed | Not confirmed | Reviewed official homepage text | No sponsor listings identified in the reviewed official content |
| Historical attendance | Not publicly confirmed in reviewed source set | Historical / unavailable | Reviewed official homepage text | No prior-year attendance data was provided in the official text excerpt |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Genomics and genetics | Sequencing workflows, analysis tools, data interpretation, sample processing | Target genomics labs, biotech R&D heads, and bioinformatics teams | Sequencing software, genomic analytics, lab instrumentation, data platforms |
| AI-driven discovery | Predictive modeling, target identification, computational pharmacology | Engage computational biology leaders and digital R&D stakeholders | AI platforms, software, cloud compute, model integration services |
| Drug discovery and precision medicine | Therapeutic discovery acceleration, biomarker analysis, translational validation | Target pharma and biotech R&D leadership, therapeutic program leads | Discovery services, CRO support, analytics, molecular platforms |
| Immunology and vaccines | Immune profiling, assay development, translational research support | Connect with immune engineering and infectious disease teams | Immunology tools, bioassays, cell analysis, consulting support |
| Neuroscience and neurotechnology | Imaging, diagnostics, neural engineering, data interpretation | Reach neurobiology labs, medtech innovators, and translational medicine teams | Imaging systems, data platforms, neurotech devices, analytics solutions |
| Regenerative medicine and organoids | Cell culture systems, validation workflows, translational platforms | Engage stem cell and organoid research leaders | Culture technologies, reagents, automation, advanced imaging |
| Microbiome and microbiology | Data pipelines, culturing tools, therapeutic validation | Relevant for biotech startups and multidisciplinary health research teams | Microbiome analytics, sequencing workflows, microbial engineering tools |
| Environmental and ecological sciences | Monitoring, biological analysis, resilience research, cross-sector collaboration | Target environmental research centers and applied life science teams | Environmental analytics, monitoring tools, ecological data systems |
| Scientific collaboration and publication pipeline | Visibility, co-authorship, knowledge exchange, partnership formation | Useful for business development and thought-leadership outreach | Research services, software, collaboration tools, innovation partnership offers |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | Relevant for life sciences tools, research services, biotech software, diagnostics, and scientific partnerships |
| Decision-maker availability | Medium | Strong technical and scientific influence is likely; direct procurement authority may vary by institution |
| Data collection potential | Medium | The public source set confirms event existence and scope, but not a validated attendee-company list |
| Apollo targeting potential | Very High | Life sciences, pharma, research, university, and bioinformatics job functions are highly targetable in Apollo |
| Geographic targeting potential | High | Virtual and global format supports multi-region campaigns across biotech hubs |
| Best outreach approach | High | Use insight-led outreach tied to conference themes such as genomics, AI drug discovery, organoids, diagnostics, and computational biology |
| Overall lead quality | High | High-value audience quality for specialized B2B offerings, though list verification is limited from public sources |
| Best use case | High | Thought-leadership campaigns, scientific software outreach, research partnerships, and targeted BD prospecting |
| Limitations / risks | Medium | Limited official disclosure of participating organizations, buyer counts, and sponsor or exhibitor lists reduces certainty for event-specific list-building |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Biotechnology; Pharmaceuticals; Research; Higher Education; Hospital & Health Care; Medical Devices; Information Technology & Services; Computer Software; Environmental Services; Agriculture; Government Administration | Capture the most likely life-science buyer and influencer organizations aligned to official event themes |
| Departments | Research; Engineering; Information Technology; Operations; Procurement; Business Development; Education; Program & Project Management | Reach scientific, technical, procurement, and partnership stakeholders |
| Seniority | C-Level; VP; Director; Head; Manager | Focus on budget holders and technical evaluators |
| Job titles | Chief Scientific Officer; VP R&D; Director of Research; Head of Bioinformatics; Principal Investigator; Clinical Research Director; Procurement Manager; Strategic Sourcing Manager; Lab Operations Manager; Partnerships Director; Business Development Director; Innovation Director | Align outreach to event-relevant scientific and commercial roles |
| Geography | United States; Canada; United Kingdom; Germany; France; Netherlands; Switzerland; Singapore; Japan; South Korea; India; Australia | Target major life-science and research hubs suitable for a global virtual conference |
| Employee size | 11–50; 51–200; 201–500; 501–1,000; 1,001–5,000; 5,001+ | Cover startups, scale-ups, universities, hospitals, and large pharma organizations |
| Keywords | genomics, synthetic biology, computational biology, AI drug discovery, microbiome, organoid, neurotechnology, precision medicine, CRISPR, biomedical imaging, immunology, bioinformatics | Improve topical fit with conference subject matter |
| Technologies | Use when relevant: cloud platforms, AI/ML stack, LIMS, sequencing analytics, data visualization, laboratory informatics | Helpful for software, platform, and digital life-science solution targeting |
| Revenue range | No single mandatory filter; test mid-market to enterprise for commercial buyers and open revenue for academia/research institutions | Maintain flexibility because many high-fit accounts are non-profit, academic, or grant-funded |
| Company type | Private; Public; Nonprofit; Educational; Government | Reflects the cross-sector composition described in the official event scope |
Suggested Apollo Search Logic: ("genomics" OR "synthetic biology" OR "computational biology" OR "AI drug discovery" OR "precision medicine" OR "microbiome" OR "organoid" OR "CRISPR" OR "biomedical imaging") AND (Director OR Head OR VP OR Chief OR Manager) AND (Research OR R&D OR Bioinformatics OR Clinical Research OR Procurement OR Partnerships).
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| LiSci 2026 Official Homepage | Official event website | Event name, conference edition, dates, virtual format, scope, thematic areas, participant profile language, and navigation references to program committee / accepted papers pages | High for confirmed published facts on homepage |
| Reviewed official source gap note | Verification note | No confirmed attendance numbers, exhibitor directory, sponsor roster, venue city, country, or organizer identity were visible in the provided official source excerpt | High confidence gap statement based on reviewed material |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 3rd International Life Sciences Conference | LiSci 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds